共创共享 共和共荣 OXIRANE CHEMICALS OXIRANE CHEMICALS OXIRANE CHEMICALS OXIRANE CHEMLIAONIINCG OXAIRALNCSHEM,.INC, | --- | --- | |-------------------|-----------------------------| | | | | | | | | | | | 2017年机构联合调研 汇报材料 | | | 浏览 | | 不忘初心 升级转型 | | 共创共享 共和共荣 报告内容 1 经营业绩回顾 2 发展战略规划 3 公司经营管理 4 新产品发布 共创共享 共和共荣 | --- | --- | --- | --- | --- | --- | --- | --- | |-------|------------------------------------------------|-----------------------|------------|----------|----------------|-----------------|------------| | | | | ...

证券代码：300082 证券简称：奥克股份 编号：2016-002 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|---------------------------------------------|--------------------------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ | 新闻发布会 □路演活动 | | | ■ 现场参观 | | | | ■ | 其他 （深交所联合辽宁证监局在公司举办"践行中国梦• | | | | 走近上市公司" 投资者开放日） | | 参与单位名称及 | 现场调研人员 : | | | 人员姓名 | 1 | 、通过万和证券、上海证券、财达证券、广发证券、华林证券、 | | | | 中国中投证券、银河证券、国元证券、江海证券、兴业证券等报 | | | 名的近 40 | 名投资者； | | | 2 | 、证券 ...

证券代码：300082 证券简称：奥克股份 编号：2017-003 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |-------------------------|-----------------------------|-------------------------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | | | 参与单位名称及 人员姓名 | 天风证券股份有限公司 刘子栋 | | | 时间 | 2017 年 9 月 5 日 | 13:30-15:00 | | 地点 | | 江苏奥克化学有限公司(江苏省扬州化学工业园区沿江路 3 号) | | | | | | 上市公司接待人 员姓名 | 证券事务代表 张玮敏 | | | 投资者关系活动 | 介绍公司 2017 | 年上半年经营情况。 | | 主要内容介绍 ...

证券代码：300082 证券简称：奥克股份 编号：2020-001 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------------------------|---------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 □分析师会议 | | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | ☑ 其他 公司 20 20 | 年中期业绩说明会 | | 参与单位名称及 | 国金证券股份有限公司 杨翼荥、孙昊昱 | | | 人员姓名 | | 广发证券股份有限公司 李洲、黄璐叶丹、何雄 | | | 光大证券股份有限公司 傅锴铭 | | | | 中信证券股份有限公司 王喆 | | | | 长城证券股份有限公司 | 濮阳 | | | 东方证券股份有限公司 倪吉 | | | | 西部证券股份有限公司 陈默 | | | | 中信建投证券股份有限公司 郑 ...

证券代码：300082 证券简称：奥克股份 编号：2018-001 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------- ...

编号：2020-002 证券代码：300082 证券简称：奥克股份 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------------------|--------------| | | | | | 投资者关系活动 | ☑ 特定对象调研 □分析师会议 | | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | ☑ 现场参观 | | | | □ 其他 | | | | 招商证券股份有限公司 | 游家训 | | | 光大证券股份有限公司 傅锴铭 | | | | 中信证券股份有限公司 | 王喆、王凯旋 | | | 东方证券股份有限公司 | 倪吉 | | | 国盛证券有限责任公司 杨义韬 | | | 参与单位名称及 | 太平洋证券股份有限公司 柳强 | | | 人员姓名 | 方正证券股份有限公司 赵小燕 | | | | 中国国际金融股份有限公司 | 吴頔 | | | 南方基金管理股份有限公司 都逸敏 | | | | 中大君悦投资有限公司 | 陈 ...

编号：2021-001 投资者关系活动 □特定对象调研 □分析师会议 类别 □媒体采访 ☑业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 证券代码：300082 证券简称：奥克股份 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------------------------|----------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300082 证券简称：奥克股份 辽宁奥克化学股份有限公司 投资者关系活动记录表 编号：2022 -001 | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------|--------------------------------------------------------------------------------------------------------------|--------------|--------------------------------------------------------|-------|-------|-------| | | | | | | | | | 投资者关系活动类别 | ☐ 特定对象调研 | ☐ 分析师会议 | | | | | | | ☐ 媒体采访 | 业绩说明会 | | | | | | | ☐ 新闻发布会 | ☐ 路演活动 | | | | | | | ☐ 现场参观 | | | | | | | | ☐其他（请文字说明其他活动内容） ...

Financial Performance - The company's revenue for Q3 2022 was ¥1,455,373,355.79, a decrease of 22.24% compared to the same period last year[4]. - The net profit attributable to shareholders was a loss of ¥38,984,070.94, down 135.48% year-on-year[4]. - The basic earnings per share were -¥0.06, reflecting a decline of 137.50% compared to the previous year[4]. - The total operating revenue for the third quarter of 2022 was CNY 4,374,107,334.73, a decrease of 12.3% compared to CNY 4,988,041,923.23 in the same period last year[24]. - The net profit for the third quarter of 2022 was CNY 16,885,335.32, down 91.9% from CNY 208,367,050.25 in the previous year[25]. - The basic earnings per share for the third quarter was CNY 0.01, down from CNY 0.28 in the same period last year, indicating a significant decline in profitability[26]. Assets and Liabilities - Total assets at the end of the reporting period were ¥6,151,350,652.98, a decrease of 9.05% from the end of the previous year[4]. - The company's total assets decreased to CNY 6,151,350,652.98 from CNY 6,763,326,789.61, reflecting a decline of 9.1%[23]. - The total liabilities decreased to CNY 2,661,354,407.20 from CNY 3,059,835,688.71, a reduction of 13.0%[23]. - The total current assets decreased from 3,274,865,984.51 CNY at the beginning of the year to 2,377,796,497.27 CNY by September 30, 2022[21]. - The total non-current assets increased to CNY 3,773,554,155.71 from CNY 3,488,460,805.10, reflecting a growth of 8.2%[23]. Cash Flow - The company reported a cash flow from operating activities of ¥121,388,900.00, which decreased by 1.60% year-to-date[4]. - The company's cash flow from operating activities showed a significant decline, impacting liquidity and operational flexibility[26]. - The net cash flow from operating activities for the current period is ¥121,388,900, a slight decrease from ¥123,363,062 in the previous period[27]. - Cash inflow from investment activities totaled ¥1,592,250,840.88, up from ¥1,223,084,240.63 in the previous period[28]. - The net cash flow from investment activities is -¥280,782,999.91, an improvement from -¥388,330,204.15 in the previous period[28]. - The net cash flow from financing activities decreased by 163.07% year-to-date, primarily due to a reduced increase in bank borrowings[12]. - The net cash flow from financing activities is -¥86,538,669.01, a decline from ¥137,202,518.84 in the previous period[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 41,583[14]. - The largest shareholder, Aoke Holdings Group, holds 52.89% of shares, totaling 359,698,573 shares, with 44,380,000 shares pledged[14]. - The top ten shareholders do not have any known relationships or agreements among them[15]. - The company has no preferred shareholders as of the reporting period[16]. Operational Changes - The company experienced a 51.37% decrease in notes receivable compared to the beginning of the year, primarily due to a reduction in discounted notes[9]. - The construction in progress increased by 128.44% year-to-date, mainly due to investments in new projects[9]. - Research and development expenses increased to CNY 42,461,480.37, up 16.5% from CNY 36,535,237.57 in the previous year, indicating a focus on innovation[24]. - The company is focusing on market expansion and new product development as part of its strategic initiatives for future growth[26]. Legal Matters - The company is involved in a lawsuit regarding a compensation claim of 175,745,194.98 CNY against Chen Yegang, with hearings held in June and August 2022[19]. - The company has submitted listing guidance materials for its associate, Wuhan Jihua Chang New Materials Co., Ltd., to the Hubei Securities Regulatory Bureau[19].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥2,918,733,978.94, a decrease of 6.35% compared to ¥3,116,538,221.72 in the same period last year[20]. - The net profit attributable to shareholders was ¥47,772,219.73, down 42.76% from ¥83,465,458.98 year-on-year[20]. - The net profit after deducting non-recurring gains and losses was ¥35,377,898.72, reflecting a decline of 49.27% compared to ¥69,739,978.21 in the previous year[20]. - The net cash flow from operating activities was ¥43,252,569.17, a significant drop of 76.31% from ¥182,606,860.56 in the same period last year[20]. - Basic earnings per share decreased to ¥0.07, down 41.67% from ¥0.12 in the previous year[20]. - Total assets at the end of the reporting period were ¥6,588,170,583.77, a decrease of 2.59% from ¥6,763,326,789.61 at the end of the previous year[20]. - The net assets attributable to shareholders decreased by 4.74% to ¥3,285,951,823.60 from ¥3,449,480,545.49 at the end of the previous year[20]. - The weighted average return on net assets was 1.42%, down 1.18 percentage points from 2.60% in the previous year[20]. - The company's revenue for the reporting period was approximately ¥2.92 billion, a decrease of 6.35% compared to ¥3.12 billion in the same period last year[44]. - The company's operating costs were approximately ¥2.73 billion, down 5.99% from ¥2.90 billion year-on-year[44]. Investment and R&D - Research and development investment amounted to approximately ¥88.07 million, a decrease of 9.23% compared to ¥97.02 million in the previous year[44]. - The company holds 111 authorized invention patents and 140 utility model patents, with 34 new patents granted in the first half of 2022[39]. - The company is focusing on technological innovation and strategic partnerships to enhance its product offerings and market position[80]. - New product development efforts are focused on enhancing chemical production efficiency, with an investment of 14.9 million planned for R&D in 2022[140]. Market and Sales - The company has a production capacity of 300,000 tons of ethylene oxide and a strategic layout of 1.6 million tons of ethoxylation capacity across various regions[28]. - The company is a leading producer of polycarboxylate superplasticizers and has established a complete industrial chain from ethylene to ethylene oxide and its derivatives[28]. - The company expects continuous growth in the sales scale of electrolyte solvents, driven by the rapid development of lithium-ion batteries in electric vehicles[30]. - In the first half of 2022, the sales volume of polycarboxylate superplasticizer decreased by 6.97% year-on-year, and the gross margin declined by 3.51%[33]. - The sales volume of pharmaceutical polyethylene glycol excipients increased by 50.37% year-on-year during the reporting period[35]. Financial Position and Cash Flow - The company's cash and cash equivalents increased to ¥629,712,902.22, representing 9.56% of total assets, up from 9.14% at the end of the previous year[51]. - Inventory rose significantly to ¥595,955,554.93, which is 9.05% of total assets, reflecting an increase in finished goods[51]. - The gross margin for polyethylene glycol was 21.63%, with revenue of ¥193,561,314.04, reflecting a year-on-year increase of 53.34%[47]. - The company reported a significant increase in sales expenses by 48.67% due to increased inventory and storage costs[44]. - The net cash flow from operating activities decreased by 76.31% to approximately ¥43.25 million, primarily due to increased inventory levels[44]. Environmental and Regulatory Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[93]. - The company reported a total COD discharge of 3.32 tons for the period, with no exceedance of discharge standards[93]. - The company has established various environmental protection facilities, including wastewater collection pools and online monitoring systems, which are all operating normally[98]. - The company has implemented a comprehensive environmental monitoring plan to manage potential pollution risks[100]. - The company’s wastewater treatment facilities across subsidiaries are functioning effectively, ensuring compliance with environmental standards[98]. Strategic Partnerships and Expansion - The company has established international platforms in Indonesia and Singapore to support its international development strategy[29]. - The company has established a strategic partnership with major clients such as Lvyang, Dongfang Yuhong, and Sika, enhancing its market competitiveness[40]. - The company is exploring market expansion opportunities in Southeast Asia, targeting a 15% market share by the end of 2023[140]. - The company is actively pursuing talent planning in line with its business strategy to enhance operational efficiency and competitiveness[38]. Legal and Compliance Issues - The company is currently involved in a contract dispute with a claim amount of CNY 2,734 million, which is still in the execution process[123]. - The company has reported a significant litigation case involving a performance commitment compensation and equity impairment compensation amounting to CNY 17,574.52 million[123]. - The average burden of the company in the ongoing litigation is expected to be significant, with multiple claims in process[124]. - The company has strengthened its collection efforts for accounts receivable and overdue payments during the reporting period[123]. Corporate Governance - The company did not distribute cash dividends or issue bonus shares for the half-year period[89]. - The company held its annual general meeting on May 20, 2022, with a participation rate of 57.80%[87]. - The company has no stock incentive plans or employee stock ownership plans in place during the reporting period[90]. - The company has committed to avoiding any substantial competition with its controlled subsidiaries and affiliates, ensuring no direct or indirect engagement in competing activities[116].